Christine is a freelance writer for Collider with two decades of experience covering all types of TV shows and movies spanning every genre. With a particular affinity for dramas, true crime, sitcoms, ...

February might be the month of roses and rom-com rewatches, but if Prime Video’s charts are anything to go by, viewers are leaning more toward thrillers than love stories this Valentine’s weekend. The ...

New from Anker (unveiled at CES 2026, launched on Feb. 2 and provided for review here), this is the world’s first Qi2.2-certified, 25W wireless charging station with active fan-cooling technology in a ...

Every American who has ever had a Social Security number may now be living with a hidden risk that never really expires. That is the warning from Chuck Borges, the former chief data officer at the ...

Anker introduced a nifty little charger at CES 2026, which is a refresh of the pre-existing Nano Charger. It's already on sale for $30 for Prime members, which is a discount of $10. The 45W charger ...

Meara covers streaming service news for CNET. She graduated from the University of Texas at Austin with a degree in journalism. When she's not writing, she likes to dote over her cat, sip black coffee ...

Presearch’s “Doppelgänger” is trying to help people discover adult creators rather than use nonconsensual deepfakes.

I hope you didn’t make any plans this weekend because Netflix, Hulu and all the other major streamers are streaming can’t-miss new movies. Watch With Us has selected the best of a very impressive ...

Shares of Recursion Pharmaceuticals RXRX are surging Wednesday following a robust earnings report released before the bell. The biotechnology firm reported a loss per share of 21 cents, surpassing the ...

Recursion Pharmaceuticals (RXRX) ended the recent trading session at $3.53, demonstrating a +2.02% change from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 0.56%.